eXoZymes, Inc. (EXOZ) Research
Operating within the United States, eXoZymes, Inc. is a pioneering synthetic biochemical enterprise. The company's primary innovation is SimplePath, a sophisticated platform engineered to synthesize a diverse spectrum of chemicals. This output encompasses essential pharmaceuticals, alternative fuels, advanced materials, food additives, and entirely new molecular entities. Integral to its design, the SimplePath platform incorporates distinct modules, each housing one or more enzymes that work synergistically to facilitate specific biocatalytic transformations. The firm was established in 2014 and maintains its corporate headquarters in Monrovia, California.
Market snapshot
- Symbol
- EXOZ
- Price
- $7.83
- Day change
- +23.70%
- Market cap
- $66.4M
- P/E ratio
- -6.85x
- 52-week range
- 6.33-18.4
- Sector
- Healthcare
- Industry
- Biotechnology
Peer companies
Recent insider activity
- Korman Tyler Paz — S-Sale (750 shares) on 2026-04-08
- Korman Tyler Paz — S-Sale (750 shares) on 2026-04-09
- Perriman Damien Alan — A-Award (146437 shares) on 2026-04-01
- Perriman Damien Alan — A-Award (62759 shares) on 2026-04-01
- Perriman Damien Alan — trade (0 shares) on 2026-04-01
Open eXoZymes, Inc. (EXOZ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.